1h Free Analyst Time
The plasma therapeutics market is forecasted to grow by USD 6.37 billion during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the plasma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high demand for albumin in China, increasing surgical procedures, and new approvals by governing bodies.
The plasma therapeutics market is segmented as below:
By Product
- Immunoglobulin
- Albumin
- Blood factors
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the plasma therapeutics market covers the following areas:
- Plasma therapeutics market sizing
- Plasma therapeutics market forecast
- Plasma therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global plasma therapeutics market: ADMA Biologics Inc., Bio Products Laboratory Ltd., BIOPHARMA PLASMA, CSL Ltd., Emergent BioSolutions Inc., Evolve Biologics Inc., Grifols SA, Kamada Ltd., Kedrion Spa, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, SK Inc., and Takeda Pharmaceutical Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is establishment of plasma fractionation facilities in developing economies by global players."
According to the report, one of the major drivers for this market is the high demand for albumin in china.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ADMA Biologics Inc.
- Bio Products Laboratory Ltd.
- BIOPHARMA PLASMA
- CSL Ltd.
- Emergent BioSolutions Inc.
- Evolve Biologics Inc.
- Grifols SA
- Kamada Ltd.
- Kedrion Spa
- Octapharma AG
- Pfizer Inc.
- Prothya Biosolutions Netherlands BV
- SK Inc.
- Takeda Pharmaceutical Co. Ltd.
